MonoSol Rx expands nanoparticle pact with Midatech; EyeGate launches pivotal trial

>  Drug delivery tech outfit MonoSol Rx expanded its pact with Midatech Group in the UK to develop nanoparticle-based proteins and peptides for therapeutic delivery using pharmaceutical films. Release

> MonoSol also announced that it has named Eric Dadey senior vice president, pharmaceutical development. Release

> Archimedes Pharma received a positive opinion from the Committee for Human Medicinal Products of the European Medicines Agency recommending PecFent, a fentanyl nasal spray, for the treatment of breakthrough cancer pain. Release

> EyeGate Pharma, which is developing a non-invasive ocular drug delivery platform and ocular drugs, has begun enrolling patients in the pivotal Phase III study of its lead product, EGP-437, for the treatment of Dry Eye Syndrome. Release

> Innomech has struck a deal to develop an end-of-line testing system for a new drug delivery pen. Story